The OECD program to validate the rat uterotrophic bioassay. Phase 2: coded single-dose studies
about
Treatment of menopausal symptoms by an extract from the roots of rhapontic rhubarb: the role of estrogen receptorsUsing a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals.Phthalate exposure and early thelarcheThe OECD program to validate the rat uterotrophic bioassay: an overview.The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies.Cumulative dietary energy intake determines the onset of puberty in female rats.The intact immature rodent uterotrophic bioassay: possible effects on assay sensitivity of vomeronasal signals from male rodents and strain differences.The estrogenic content of rodent diets, bedding, cages, and water bottles and its effect on bisphenol A studiesUsing systematic reviews for hazard and risk assessment of endocrine disrupting chemicalsTamoxifen-elicited uterotrophy: cross-species and cross-ligand analysis of the gene expression programStatistical inference under order restrictions in analysis of covariance using a modified restricted maximum likelihood estimator.Comparative uterotrophic effects of endoxifen and tamoxifen in ovariectomized Sprague-Dawley rats.The OECD program to validate the rat Hershberger bioassay to screen compounds for in vivo androgen and antiandrogen responses. Phase 1: use of a potent agonist and a potent antagonist to test the standardized protocol.Key learnings from the Endocrine Disruptor Screening Program (EDSP) Tier 1 rodent uterotrophic and Hershberger assays.Use of the laboratory rat as a model in endocrine disruptor screening and testing.Variations in phytoestrogen content between different mill dates of the same diet produces significant differences in the time of vaginal opening in CD-1 mice and F344 rats but not in CD Sprague-Dawley rats.Effects of chronic genistein treatment in mammary gland, uterus, and vagina.Oral p-tert-octylphenol exposures induce minimal toxic or estrogenic effects in adult female Sprague-Dawley rats.Evaluation of the scientific underpinnings for identifying estrogenic chemicals in nonmammalian taxa using mammalian test systems.Cross-species conservation of endocrine pathways: a critical analysis of tier 1 fish and rat screening assays with 12 model chemicals.Relevance weighting of tier 1 endocrine screening endpoints by rank order.Phthalate exposure in girls during early puberty.A cross-species analysis of the rodent uterotrophic program: elucidation of conserved responses and targets of estrogen signaling.Effects of a glyphosate-based herbicide on the uterus of adult ovariectomized rats.High urinary phthalate concentration associated with delayed pubarche in girls.Determination of in vivo estrogenic potential of Di-isobutyl phthalate (DIBP) and Di-isononyl phthalate (DINP) in rats.Diosgenin does not express estrogenic activity: a uterotrophic assay.Assessment of estrogenic potential of di-n-butyl phthalate and butyl benzyl phthalate in vivo.Genistein affects ovarian folliculogenesis: a stereological study.Interpreting estrogen screening assays in the context of potency and human exposure relative to natural exposures to phytoestrogens.
P2860
Q21203060-71E4725B-B607-4CB7-8B34-0D431F3FCA9EQ24812374-ADED96AC-50C7-410C-B09A-7688B1281CFDQ24815264-C7985F50-6FA2-4EC2-9808-95C4EA494C99Q24816099-5C5750BF-8093-4E33-A3C4-53B5683ACBF4Q24816107-76AA9045-C363-4D4E-A62E-28827A7B3F87Q24816122-436C9883-1DE7-421E-B411-06AA1AB601DDQ24816146-CBF3BAB7-6A01-45DF-BA2B-98A6457A1278Q26824437-63278F9B-AD84-4863-8685-6E84C2E74826Q28079859-DC40DF13-C502-43A3-B59C-C5FE24363477Q33436073-DD904541-A52B-4A24-B0EE-4F27F88BF9F1Q34204519-AC1EFE85-430B-4D9C-BFFD-709128DED21AQ34253146-A84F26BA-DD91-4109-B931-F78880619239Q35001737-7129D028-C408-4F36-91B7-085F7B04BB94Q35023310-ECA41894-BBC9-47C6-9D3A-A8BC16963506Q35904245-40A45994-8856-4CE3-ABEC-7B85450589B1Q36264552-FF337BCC-4EB4-4C7B-9842-000BC655C969Q36326624-3F365656-07D5-4B6A-90BF-3B0222D57CB6Q39714992-BC43F89D-54F6-4B34-AA32-BB6FA78E4C9AQ39854165-8D1A8AFA-C6DD-4EB6-BE04-1A73DD4B5767Q42686927-4917EFA0-3D62-4722-9612-B8C987C4E6A3Q45233038-9B2A7E22-4688-494A-B3C9-FBC15FF0F745Q46062735-6AD8E242-7389-4ECF-9F86-BF7DD7AC9212Q46713405-26F76B31-64FD-4359-85B0-A4983E9D345AQ48140502-C6A29FCB-8A9C-4173-9EB9-9281BE17BB55Q50956755-D5A628E5-A8A5-4646-94E0-165C55628F96Q51005236-5FE438F0-1E4C-4B47-BC0F-AB1E2DD01BEAQ51148377-F997D907-4A1E-43D0-B186-47DF16AA0DB2Q51226681-4E0A636C-243E-46A6-A36C-33115AB60FFBQ51315237-216C7F00-13D8-4D0C-B653-DE95C10C10F7Q52646601-875400E9-5C3E-4D2E-BA08-CC51C499866F
P2860
The OECD program to validate the rat uterotrophic bioassay. Phase 2: coded single-dose studies
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
The OECD program to validate t ...... e 2: coded single-dose studies
@ast
The OECD program to validate t ...... e 2: coded single-dose studies
@en
The OECD program to validate t ...... e 2: coded single-dose studies
@nl
type
label
The OECD program to validate t ...... e 2: coded single-dose studies
@ast
The OECD program to validate t ...... e 2: coded single-dose studies
@en
The OECD program to validate t ...... e 2: coded single-dose studies
@nl
prefLabel
The OECD program to validate t ...... e 2: coded single-dose studies
@ast
The OECD program to validate t ...... e 2: coded single-dose studies
@en
The OECD program to validate t ...... e 2: coded single-dose studies
@nl
P2093
P2860
P356
P1476
The OECD program to validate t ...... e 2: coded single-dose studies
@en
P2093
Elard Jacob
John Ashby
Lesley Onyon
Shyamal Peddada
William Owens
P2860
P304
P356
10.1289/EHP.5870
P407
P577
2003-09-01T00:00:00Z